1. Home
  2. NEOG vs NVAX Comparison

NEOG vs NVAX Comparison

Compare NEOG & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEOG
  • NVAX
  • Stock Information
  • Founded
  • NEOG 1981
  • NVAX 1987
  • Country
  • NEOG United States
  • NVAX United States
  • Employees
  • NEOG N/A
  • NVAX N/A
  • Industry
  • NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NEOG Health Care
  • NVAX Health Care
  • Exchange
  • NEOG Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • NEOG 1.3B
  • NVAX 1.4B
  • IPO Year
  • NEOG 1989
  • NVAX 1995
  • Fundamental
  • Price
  • NEOG $6.36
  • NVAX $7.41
  • Analyst Decision
  • NEOG Buy
  • NVAX Hold
  • Analyst Count
  • NEOG 4
  • NVAX 7
  • Target Price
  • NEOG $8.83
  • NVAX $10.71
  • AVG Volume (30 Days)
  • NEOG 3.4M
  • NVAX 4.2M
  • Earning Date
  • NEOG 10-09-2025
  • NVAX 11-06-2025
  • Dividend Yield
  • NEOG N/A
  • NVAX N/A
  • EPS Growth
  • NEOG N/A
  • NVAX N/A
  • EPS
  • NEOG N/A
  • NVAX 2.07
  • Revenue
  • NEOG $886,886,000.00
  • NVAX $1,064,651,000.00
  • Revenue This Year
  • NEOG N/A
  • NVAX $59.49
  • Revenue Next Year
  • NEOG $1.80
  • NVAX N/A
  • P/E Ratio
  • NEOG N/A
  • NVAX $3.60
  • Revenue Growth
  • NEOG N/A
  • NVAX 20.27
  • 52 Week Low
  • NEOG $3.87
  • NVAX $5.01
  • 52 Week High
  • NEOG $16.79
  • NVAX $11.55
  • Technical
  • Relative Strength Index (RSI)
  • NEOG 56.57
  • NVAX 35.58
  • Support Level
  • NEOG $5.91
  • NVAX $7.50
  • Resistance Level
  • NEOG $6.32
  • NVAX $7.90
  • Average True Range (ATR)
  • NEOG 0.31
  • NVAX 0.34
  • MACD
  • NEOG -0.01
  • NVAX -0.12
  • Stochastic Oscillator
  • NEOG 78.91
  • NVAX 8.02

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: